ArticleBrain, behavior, & immunity - health2022

Safety and efficacy of low dose naltrexone in a long covid cohort; an interventional pre-post study.

Brendan O'Kelly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.